On October 26, WUXI APPTEC fell 3.17% in regular trading, trading at HK$180.3, with turnover of HK$393 million.
The move coincided with broad weakness across the Life Sciences Tools & Services group and a rise in short-term positioning ahead of the company’s results announcement on October 26. In the same sector, WUXI BIO fell 2.88%, WUXI XDC fell 4.0%, INSILICO fell 4.99%, XTALPI fell 1.24%, and GENSCRIPT B-1K fell 1.58%.
Supporting context shows market expectations for the quarter remain constructive, with consensus forecasting revenue of RMB15.30 billion, up 34.65% year over year, and adjusted EPS of RMB1.81, up 77.71% year over year. At the same time, recent block trades indicate intensified capital rotation, including a RMB96.31 million transaction on October 23 and 31 block trades over the past three months, highlighting elevated short-term trading activity around the earnings window.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments